Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$4.41 - $5.69 $28,665 - $36,985
-6,500 Reduced 34.03%
12,600 $67,000
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $7,214 - $10,485
-1,500 Reduced 7.28%
19,100 $105,000
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $4,179 - $5,551
-700 Reduced 3.29%
20,600 $140,000
Q2 2021

Aug 12, 2021

SELL
$5.35 - $6.35 $1,070 - $1,270
-200 Reduced 0.93%
21,300 $126,000
Q1 2021

May 17, 2021

SELL
$5.68 - $7.87 $6,248 - $8,657
-1,100 Reduced 4.87%
21,500 $129,000
Q4 2020

Feb 09, 2021

BUY
$5.25 - $8.56 $4,725 - $7,704
900 Added 4.15%
22,600 $156,000
Q3 2020

Nov 12, 2020

SELL
$5.78 - $7.47 $1,734 - $2,241
-300 Reduced 1.36%
21,700 $136,000
Q2 2020

Jul 27, 2020

SELL
$4.5 - $7.02 $2,700 - $4,212
-600 Reduced 2.65%
22,000 $145,000
Q1 2020

May 13, 2020

BUY
$2.87 - $5.49 $5,740 - $10,980
2,000 Added 9.71%
22,600 $105,000
Q3 2019

Oct 15, 2019

SELL
$4.86 - $6.05 $1,458 - $1,815
-300 Reduced 1.44%
20,600 $106,000
Q4 2018

Feb 13, 2019

SELL
$4.89 - $7.16 $4,401 - $6,444
-900 Reduced 4.13%
20,900 $106,000
Q1 2018

Apr 20, 2018

SELL
$3.56 - $5.74 $1,780 - $2,870
-500 Reduced 2.24%
21,800 $119,000
Q4 2017

Feb 02, 2018

BUY
$2.76 - $3.95 $61,547 - $88,085
22,300
22,300 $75,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.